Development and Characterization of Thermoresponsive In Situ Nasal Gel of Rizatriptan for Migraine

Authors

  • Penmetsa hyma harshitha, Praveen Gujjula, Dr. D. Raghava, Dr. Kavala Nageswara Rao Author

DOI:

https://doi.org/10.48047/

Keywords:

Rizatriptan, Thermoresponsive nasal gel, In situ gelation, Mucoadhesive polymer, Mucoadhesive polymer, Migraine management

Abstract

Rizatriptan, a 5-HT1B/1D receptor agonist, is commonly prescribed for acute migraine attacks but suffers from low oral bioavailability due to first-pass metabolism. To overcome this limitation and ensure rapid onset of action

Downloads

Download data is not yet available.

References

Thakkar, J. H., & Prajapati, S. T. (2021). Formulation development and characterization of in-situ gel of Rizatriptan Benzoate for intranasal delivery. Journal of Drug Delivery and Therapeutics, 11(1-s), 1–6.

Agarwal, P., Kumar, A., Tanwar, Y. S., & Sharma, S. (2017). Formulation and evaluation of in-situ nasal gel of Rizatriptan Benzoate by using mucoadhesive polymers. Journal of Drug Delivery and Therapeutics, 7(2), 183–187.

Downloads

Published

2025-10-07

How to Cite

Penmetsa hyma harshitha, Praveen Gujjula, Dr. D. Raghava, Dr. Kavala Nageswara Rao. (2025). Development and Characterization of Thermoresponsive In Situ Nasal Gel of Rizatriptan for Migraine . History of Medicine, 11(2), 81-86. https://doi.org/10.48047/